Novel investigational therapies for onychomycosis: an update

In VitroAntifungal Activity of ME1111, a New Topical Agent for Onychomycosis, against Clinical Isolates of Dermatophytes

(2015) M. Ghannoum et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

VT-1161 Dosed Once Daily or Once Weekly Exhibits Potent Efficacy in Treatment of Dermatophytosis in a Guinea Pig Model

(2015) E. P. Garvey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

UV-curable gel formulations: Potential drug carriers for the topical treatment of nail diseases

(2015) Laxmi Valji Kerai et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis:in vitroandin vivoevaluation

(2015) Sakine Tuncay Tanrıverdi et al.   JOURNAL OF LIPOSOME RESEARCH

Tazarotene as alternative topical treatment for onychomycosis

(2015) Elena Campione et al.   Drug Design Development and Therapy

The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme

(2014) A. G. S. Warrilow et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Design and optimization of highly-selective fungal CYP51 inhibitors

(2014) William J. Hoekstra et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Tavaborole: First Global Approval

(2014) Anthony Markham   DRUGS

New pharmacotherapy for the treatment of onychomycosis: an update

(2014) Aditya K Gupta et al.   EXPERT OPINION ON PHARMACOTHERAPY

Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream

(2014) Eun-Hwa Lim et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Therapies for the treatment of onychomycosis

(2013) Aditya K. Gupta et al.   CLINICS IN DERMATOLOGY

A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis

(2013) Bárður Sigurgeirsson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Onychopharmacokinetics of terbinafine hydrochloride penetration from a novel topical formulation into the human nail in vitro

(2012) Xiaoying Hui et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Fractionated Carbon Dioxide Laser Treatment of Photoaging: Prospective Study in 45 Patients and Review of the Literature

(2011) EMILY P. TIERNEY et al.   DERMATOLOGIC SURGERY

Fractionated CO2 laser skin rejuvenation

(2011) Emily P. Tierney et al.   Dermatologic Therapy

Systematic review of nondermatophyte mold onychomycosis: Diagnosis, clinical types, epidemiology, and treatment

(2011) Aditya K. Gupta et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Niveau de preuve du suivi thérapeutique pharmacologique du voriconazole

(2011) Anne Hulin et al.   THERAPIE

Obezite ile İlişkili Dermatozların Obezlerde ve Aşırı Kilolularda Araştırılması

(2011) Nurhan Döner et al.   TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY

Onychomycosis

(2010) Oliverio Welsh et al.   CLINICS IN DERMATOLOGY

The nail in the elderly

(2010) Robert Baran   CLINICS IN DERMATOLOGY

Skin infections in Egyptian renal transplant recipients

(2010) N.I. Bakr et al.   Transplant Infectious Disease

Enhancing the nail permeability of topically applied drugs

(2008) Sudaxshina Murdan   Expert Opinion on Drug Delivery